Earnings Call · Q4 FY2023·2024-02-22

Q4 23EPS +5.88%·Rev n/aQ3 23EPS -0.59%·Rev n/aQ2 23EPS -5.47%·Rev n/aQ1 23EPS -20.83%·Rev n/a⚠ consensus missing

IMMUNIC, INC. IMUX

Jessica Breu — Vice President, Investor Relations and Communications

Daniel Vitt — Chief Executive Officer

Glenn Whaley — Chief Financial Officer

−4.7%1d on move date−6.8% vs SPY3d0.0%5d+9.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IMUX calls or request research access.

More IMUX calls Browse calls Request research access